KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Eli Lilly (LLY) over the last 17 years, with Q4 2025 value amounting to -$2.8 billion.

  • Eli Lilly's Cash from Investing Activities fell 4587.19% to -$2.8 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$11.0 billion, marking a year-over-year decrease of 1795.31%. This contributed to the annual value of -$11.0 billion for FY2025, which is 1795.31% down from last year.
  • As of Q4 2025, Eli Lilly's Cash from Investing Activities stood at -$2.8 billion, which was down 4587.19% from -$3.0 billion recorded in Q3 2025.
  • Over the past 5 years, Eli Lilly's Cash from Investing Activities peaked at -$459.1 million during Q2 2023, and registered a low of -$4.0 billion during Q3 2024.
  • In the last 5 years, Eli Lilly's Cash from Investing Activities had a median value of -$1.2 billion in 2021 and averaged -$1.7 billion.
  • In the last 5 years, Eli Lilly's Cash from Investing Activities skyrocketed by 4445.25% in 2023 and then plummeted by 37891.53% in 2024.
  • Over the past 5 years, Eli Lilly's Cash from Investing Activities (Quarter) stood at -$484.2 million in 2021, then tumbled by 94.86% to -$943.5 million in 2022, then plummeted by 209.97% to -$2.9 billion in 2023, then surged by 34.32% to -$1.9 billion in 2024, then crashed by 45.87% to -$2.8 billion in 2025.
  • Its last three reported values are -$2.8 billion in Q4 2025, -$3.0 billion for Q3 2025, and -$1.8 billion during Q2 2025.